• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD CARIBE LTD. BD MICROTAINER® TUBES WITH K2E (K2EDTA); BLOOD SPECIMEN COLLECTION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD CARIBE LTD. BD MICROTAINER® TUBES WITH K2E (K2EDTA); BLOOD SPECIMEN COLLECTION DEVICE Back to Search Results
Model Number 365974
Device Problems Nonstandard Device (1420); Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/19/2019
Event Type  malfunction  
Manufacturer Narrative
Date of event: unknown.The date received by manufacturer has been used for this field.Investigation summary: this complaint is associated to field action # 2243072-05/09/2019-007-r.Bd had not received samples or photos from the customer facility for evaluation.Retention samples were selected from bd inventory for evaluation/testing and upon completion, the customer's indicated failure mode for clotting was observed.A review of the device history record was completed for the incident lot and, based on this review, all product specifications and requirements for lot release were met; there were no related quality non-conformances during manufacturing of the product.Bd has initiated further investigation relating to this issue through capa # (b)(4) and potential causes have been identified.As a result, corrective actions have been established and are in the process of being implemented.Root cause description a capa # (b)(4) was conducted to document further investigation and root cause analysis relating to this issue.The investigation has identified the most likely root causes and corrective actions are in the process of being implemented.Rationale: based on an assessment of severity and frequency, it was determined that a capa is required at this time in order to determine the root cause associated with this issue.The investigation has identified potential root cause(s) for this issue and corrective actions are in the process of being implemented.Additional investigation information for recall: 1.Recall summary.--------------------- bd is conducting a voluntary medical device recall for multiple lots of the bd microtainer® tube w/ bd microgardtm closure, k2edta additive, based on confirmed complaints of reduced within the tube reservoir.2.Product and scope: ------------------------- bd microtainer® tube w/ bd microgardtm closure, k2edta additive, catalog# 365974, are used to collect, transport and store skin puncture blood specimens for hematology tests, or for tests utilizing serum or heparinized plasma.3.Description of issue: ------------------------- the referenced lots have been confirmed to have reduced or no additive within the tube reservoir.Bd pas identified this issue thru the bd complaint investigation system.4.Summary table of the # of complaints and mdrs in scope.------------------------------------------------------------------- per 806 # 2243072-05/09/2019-007-r dated june 5, 2019 there were a total of 2 complaints and 2 mdrs within scope at the time the field action was made.5.Hhe summary: -------------------------------- this issue may develop visible clots within the tube samples or micro clots that are not easily detected during visual inspection of the tubes.As a result, this may lead to recollection of samples or, retesting of patients, resulting in delayed reporting of test results and patient treatment.Additionally, if a micro clot is undetected, it may contribute to inaccurate cell counts including platelet, and hemoglobin levels that could potentially produce erroneous results that impact patient treatment.This may lead to moderate health hazard to patients.6.Investigation summary: --------------------------------------- evaluation of complaint samples confirmed that additive was not visually present inside the tubes.Subsequently, retention lot samples from prior and post manufacture of the complaint lot were tested and confirmed the defect was limited to 13 lots manufactured from january 2019 to february 2019.Bd pas has initiated capa (b)(4) to further investigate this issue and implement corrective actions.7.Recall reference #, either bd internal or res/z# bd recall # pas-19-1526.
 
Event Description
It was reported that after use clotting occurred with a bd microtainer® tubes with k2e (k2edta).The following information was provided by the initial reporter: it is reported customer observed several occurrences of samples clotting.Customer is unsure how long specimen was left sitting or order of draw but specimens were not sent for testing.Specimens that clotted were discarded and she confirmed having unused tubes from the same lot to send in for investigation.They have pulled this specific lot from inventory and haven't experienced any clotting issues since using a different lot number.
 
Event Description
It was reported that after use clotting occurred with a bd microtainer® tubes with k2e (k2edta).The following information was provided by the initial reporter: it is reported customer observed several occurrences of samples clotting.Customer is unsure how long specimen was left sitting or order of draw but specimens were not sent for testing.Specimens that clotted were discarded and she confirmed having unused tubes from the same lot to send in for investigation.They have pulled this specific lot from inventory and haven't experienced any clotting issues since using a different lot number.
 
Manufacturer Narrative
Investigation summary: this complaint is associated to field action # 2243072-05/09/2019-007-r.Bd received samples from the customer facility for investigation.The samples were evaluated and the customer's indicated failure mode relating to clotting with the incident lot was observed.Additionally, retention samples were selected from bd inventory for evaluation/testing and upon completion, the customer's indicated failure mode for clotting was observed.A review of the device history record was completed for the incident lot and, based on this review, all product specifications and requirements for lot release were met; there were no related quality non-conformances during manufacturing of the product.Bd has initiated further investigation relating to this issue through a capa and potential causes have been identified.As a result, corrective actions have been established and are in the process of being implemented.
 
Event Description
It was reported that after use clotting occurred with a bd microtainer® tubes with k2e (k2edta).The following information was provided by the initial reporter: it is reported customer observed several occurrences of samples clotting.Customer is unsure how long specimen was left sitting or order of draw but specimens were not sent for testing.Specimens that clotted were discarded and she confirmed having unused tubes from the same lot to send in for investigation.They have pulled this specific lot from inventory and haven't experienced any clotting issues since using a different lot number.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD MICROTAINER® TUBES WITH K2E (K2EDTA)
Type of Device
BLOOD SPECIMEN COLLECTION DEVICE
Manufacturer (Section D)
BD CARIBE LTD.
road 31
k.m. 24.3
juncos
Manufacturer (Section G)
BD CARIBE LTD.
road 31
k.m. 24.3
juncos
Manufacturer Contact
brett wilko
9450 south state street
sandy, UT 84070
8015652341
MDR Report Key9437934
MDR Text Key176275085
Report Number2618282-2019-00286
Device Sequence Number1
Product Code JKA
UDI-Device Identifier50382903659741
UDI-Public50382903659741
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K991702
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Reporter Occupation Other Health Care Professional
Remedial Action Recall
Type of Report Initial,Followup,Followup
Report Date 01/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/09/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date07/31/2020
Device Model Number365974
Device Catalogue Number365974
Device Lot Number9052823
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/19/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/21/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction Number2243072-05/09/2019-007-R
Patient Sequence Number1
Patient Outcome(s) Other;
-
-